Danilon equidos 1.5 g Granules for horses and ponies
Danilon equidos 1.5 g Granules for horses and ponies
Authorised
- Suxibuzone
Product identification
Medicine name:
Danilon equidos 1.5 g Granules for horses and ponies
Danilon equidos 1,5 g granulátum A.U.V.
Active substance:
- Suxibuzone
Target species:
-
Horse
-
Horse (pony)
Route of administration:
-
In-feed use
Product details
Active substance and strength:
-
Suxibuzone1.50/gram(s)10.00gram(s)
Pharmaceutical form:
-
Granules
Withdrawal period by route of administration:
-
In-feed use
-
Horse
-
Meat and offalno withdrawal periodNot to be used in animals intended for human consumption. Treated horses may never be slaughtered for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation.
-
Milkno withdrawal periodNot to be used in animals intended for human consumption. Treated horses may never be slaughtered for human consumption. The horse must have been declared as not intended for human consumption under national horse passport legislation.
-
-
Horse (pony)
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Hungary
Package description:
- (ID2) 600 gram(s): Box with 60 Bag (Paper; Aluminium; PolyEthylene) each with 10 gram(s)
- (ID1) 180 gram(s): Box with 18 Bag (Paper; Aluminium; PolyEthylene) each with 10 gram(s)
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ecuphar Veterinaria S.L.U.
Marketing authorisation date:
Manufacturing sites for batch release:
- Esteve Pharmaceuticals S.A.
Responsible authority:
- Directorate Of Veterinary Medicinal Products
Authorisation number:
- 2978/X/11 MgSzH ÁTI
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0192/001
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Estonia
-
Hungary
-
Iceland
-
Latvia
-
Lithuania
-
Norway
-
Poland
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Hungarian (PDF)
Published on: 25/02/2022
Summary of Product Characteristics
English (PDF)
Download Published on: 10/08/2022
How useful was this page?:
